Dendritic cells present in negative SLN appear to be more tolerogenic than those within the primary tumour because, although the median expression of ILT3 remains stable, the expression of both IDO and TGFβ1 increases (IDO 4.02, TGFβ1 2.37; Table 1). This evidence concerns the gene LILRB4 and neoplasm.